Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
Issues
2010
June 2010, Vol 1, No 2
June 2010, Vol 1, No 2
Linked Databases, Health IT, and Informatics Essential for CER and Personalized Medicine
AACR Annual Meeting
,
Comparative Effectiveness Research
June 2010, Vol 1, No 2
Washington, DC—Health information technology (IT) and informatics are fundamental to all comparative effectiveness research (CER), Amy Abernethy, MD, associate director of the Duke Comprehensive Medical Center and founder and director of the Duke Cancer Care Research Program, told attendees at a session of the American Association of Cancer Research (AACR) 101st Annual Meeting.
Read Article
From Dollars to Sense
Comparative Effectiveness
June 2010, Vol 1, No 2
With the inclusion of $1.1 billion in the American Recovery and Reinvest ment Act of 2009 for comparative effectiveness research (CER), this topic has suddenly become a matter of great importance in the clinical and research communities.
Read Article
Breast and Ovarian Cancer Testing After the Myriad Genetics Decision
By
Rosemary Frei, MSc
Genetic Testing
,
Personalized Medicine
June 2010, Vol 1, No 2
There’s no question that when, on March 29, a federal district court judge ruled the patents held by Myriad Genetics to the
BRCA1
and
2
gene mutation sequences are invalid, a shock went through the healthcare and genetics communities.
Read Article
Page 3 of 3
1
2
3
View the Latest Issue of VBCC
Read Issue
Top Trending Articles
1.
Medication Assurance Programs, as Deceiving and Harmful as Alternate Funding Programs
Dawn Holcombe, MBA, FACMPE, ACHE
2.
Addressing Challenges to Adoption of Value-Based Agreements
Phoebe Starr
3.
Luspatercept Yields Improved Transfusion Independence Compared With Epoetin Alfa in Patients With Lower-Risk MDS
Phoebe Starr
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma